Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice

Mutations in Rhodopsin (RHO) gene commonly cause autosomal dominant retinitis pigmentosa (adRP) without effective therapeutic treatment so far. Compared with genomic DNA-targeting CRISPR-Cas9 system, Cas13 edits RNA for therapeutic applications, avoiding the risk of causing permanent changes in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Zixiang, Yao, Yuqin, Li, Luyao, Cai, Lingqiong, Zhang, Haiwei, Zhang, Shenghai, Xiao, Qingquan, Wang, Xing, Zuo, Erwei, Xu, Chunlong, Wu, Jihong, Yang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445100/
https://www.ncbi.nlm.nih.gov/pubmed/37621413
http://dx.doi.org/10.1016/j.omtn.2023.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445100/
https://www.ncbi.nlm.nih.gov/pubmed/37621413
http://dx.doi.org/10.1016/j.omtn.2023.08.002

Ejemplares similares